A carregar...

Clinical Performance of a Novel LIAISON Fecal Calprotectin Assay for Differentiation of Inflammatory Bowel Disease From Irritable Bowel Syndrome

The goal of this study was to assess the clinical performance of an investigational in vitro fecal calprotectin immunoassay for differentiating inflammatory bowel disease (IBD) from irritable bowel syndrome (IBS). BACKGROUND: Fecal calprotectin is a stool biomarker that can assist in the detection o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Gastroenterol
Main Authors: Campbell, James P., Zierold, Claudia, Rode, Ashli M., Blocki, Frank A., Vaughn, Byron P.
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2021
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7960147/
https://ncbi.nlm.nih.gov/pubmed/32324678
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MCG.0000000000001359
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!